Just to add, insomnia is not what I’m interested in. Pain management- is the massive playing card as is cancer. It’s all a gamble - but if they can prove that MM plays a major role in either of those areas, and hold the patents, then we are looking at the next “Amazon” in terms of share price. Won’t get that far because someone would buy them out probably even before 1 dollar share territory.
- Forums
- ASX - By Stock
- ZLD
- Ann: Zelira Meets Primary Endpoints for Insomnia Trial
Ann: Zelira Meets Primary Endpoints for Insomnia Trial, page-104
Featured News
Add ZLD (ASX) to my watchlist
(20min delay)
|
|||||
Last
75.0¢ |
Change
0.010(1.35%) |
Mkt cap ! $8.396M |
Open | High | Low | Value | Volume |
74.0¢ | 78.0¢ | 74.0¢ | $1.582K | 2.04K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 988 | 75.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
77.5¢ | 5 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 988 | 0.750 |
1 | 250 | 0.700 |
1 | 3429 | 0.660 |
1 | 7760 | 0.655 |
2 | 10910 | 0.650 |
Price($) | Vol. | No. |
---|---|---|
0.775 | 5 | 1 |
0.780 | 6192 | 1 |
0.800 | 480 | 2 |
0.820 | 700 | 1 |
0.900 | 5000 | 1 |
Last trade - 14.45pm 06/11/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |